What's breaking now, across thousands of outlets.
Though it's no longer unusual for a startup to emerge with an investigational drug from China, an immunology biotech is adding that asset to two immune-resetting drugs it already discovered in-house. Boulevard ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the startup is advancing a trio of multifaceted antibodies with the potential to treat several immune diseases.
German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now he's co-founding his own company.
When I was younger, female biology was seen as something to be overcome. Now we can talk about the reality of living in our bodies Have you got the “ luteal uglies ”?
And what to do about it
Calls for speed limiters or mandated helmet use after research into injuries at three paediatric trauma centres The number of children involved in crashes on e-scooters has soared in recent years…
Calls for speed limiters or mandated helmet use after research into injuries at three paediatric trauma centres The number of children involved in crashes on e-scooters has soared in recent years…
